Abstract
Abstract
Introduction
Pooled procurement of health commodities has increasingly been promoted as a solution to reduce prices, increase availability, and achieve more efficient procurement processes. However, little is known about what is required to implement pooled procurement mechanisms successfully and how they function under specific circumstances. Therefore, the aim of this systematic review is to synthesize empirically grounded insights by identifying the elements that are essential for setting up and operating pooled procurement mechanisms of medicines and vaccines.
Methods
Our review was based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We searched PubMed, Scopus and Web of Science for empirical studies on pooled procurement of medicines and vaccines using various search terms. Publications were assessed based on predetermined eligibility criteria.
Results
Our initial search yielded 1596 publications, of which 44 were eventually included in our review. Most of the included articles focused on pooled procurement mechanisms that operated on a sub-national level (43%), procured a variety of products (38%), and were set up with the goal to contain costs (64%). The review identified several elements that are essential for pooled procurement mechanisms to function. We organized these elements around three key actors in the mechanism: buyers, the pooled procurement organization, and suppliers. To participate in pooled procurement, buyers need a sufficient level of technical capacity, financial capacity and compatible laws and regulations. To carry out pooled procurement, the pooled procurement organization needs sufficient financial capacity, technical capacity, and independent operations. To supply the mechanism with health commodities, suppliers need sufficient incentives, such as a sufficient market size and a prompt payment mechanism.
Conclusion
Pooled procurement mechanisms are very diverse. They differ in characteristics and organizational structures and are set up to achieve a variety of goals. While certain essential elements are more likely to increase successful implementation and functioning of pooled procurement mechanisms, the organizational structure must be aligned with the goals of the mechanism, and adapted to the local contextual environment.
Funder
United States Pharmacopeia (USP) Quality Institute
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference75 articles.
1. Pisani E, Nistor A-L, Hasnida A, Parmaksiz K, Xu J, Kok MO. Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia. Turkey and Romania Wellcome Open Research. 2019;4:70.
2. Seiter A. A Practical Approach to Pharmaceutical Policy. World Bank. 2010; Available from: https://openknowledge-worldbank-org.eur.idm.oclc.org/handle/10986/2468.
3. Nemzoff C, Chalkidou K, Over M. Aggregating demand for pharmaceuticals is appealing, but pooling is not a panacea. Center for Global Development. 2019; Available from: https://www.cgdev.org/sites/default/files/aggregating-demand-pharmaceuticals-appealing-pooling-not-panacea.pdf.
4. Management Science for Health. MDS-3: managing access to medicines and health technologies (third edition). Arlington, VA: Management Science for Health; 2012. Available from: http://apps.who.int/medicinedocs/documents/s19577en/s19577en.pdf
5. Espín J, Rovira J, Calleja A, Azzopardi-Muscat N, Richardson E, Palm W, et al. How can voluntary cross-border collaboration in public procurement improve access to health technologies in Europe? Copenhagen: WHO Regional Office for Europe; 2016. Report No.: 21. Available from: http://ncbi.nlm.nih.gov.eur.idm.oclc.org/books/NBK464528/
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献